🇺🇸 FDA
Patent

US 7332645

IL-21 as a regulator of immunoglobin production

granted A61PA61P43/00

Quick answer

US patent 7332645 (IL-21 as a regulator of immunoglobin production) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 19 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P43/00